New directions in R&D: Current and prospective challenges

R and D Management

Volumn 38, Issue 3, 2008, Pages 241-252

  Howells, Jeremy ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 43849108275     PISSN: 00336807     EISSN: 14679310     Source Type: Journal    
DOI: 10.1111/j.1467-9310.2008.00519.x     Document Type: Article

References (55)

1. Bolten, B.M. DeGregorio, T. (2002) Trends in development cycles. Nature Reviews: Drug Discovery, 1, 335 336.
2. Callahan, J. Lasry, E. (2004) The importance of customer input in the development of very new products. R&D Management, 34, 107 120.
3. Chang, Y.-C. (2003) Benefits of co-operation on innovative performance: evidence from integrated circuits and biotechnology firms in the UK and Taiwan. R&D Management, 33, 425 438.
4. Chen, S.-H. (1997) Decision-making in research and development collaboration. Research Policy, 26, 121 135.
5. Chen, S.-H. (2004) Taiwanese IT firms' offshore R&D in China and the connection with the global innovation network. Research Policy, 33, 337 349.
6. Chesbrough, H. (2003a) The era of open innovation. MIT Sloan Management Review, 44, 35 41.
7. Chesbrough, H. (2003b) The logic of open innovation: managing intellectual property. California Management Review, 45, 33 58.
8. Chiesa, V. Manzini, R. (1997) Managing virtual R&D organizations: lessons from the pharmaceutical industry. International Journal of Technology Management, 13, 471 485.
9. Cohen, W.M. Levinthal, D.A. (1990) Absorptive capacity: a new perspective on learning and innovation. Administrative Science Quarterly, 35, 128 152.
10. Commission of the European Communities (1989) A Framework for Community RTD Action in the 90s Discussion Document, Commission of the European Communities, Brussels.
11. Commission of the European Communities (2002) More Research for Europe - Towards 3% of GDP. COM (2002) 499 Final, Communication from the Commission, Commission of the European Communities, Brussels.
12. Commission of the European Communities (2003) Investing in Research: An Action Plan for Europe. COM (2003) 226 Final, Communication from the Commission, Commission of the European Communities, Brussels.
13. Coombs, R. Metcalfe, J.S. (2002) Innovation in pharmaceuticals: perspectives on coordination, combination and creation of capabilities. Technology Analysis and Strategic Management, 14, 261 271.
14. DiMasi, J.A. (2000) New drug innovation and pharmaceutical industry structure: trends in the output of pharmaceutical firms. Drug Information Journal, 34, 1169 1194.
15. DiMasi, J.A., Hansen, R.W. Grabowski, H.G. (2003) The price of innovation: new estimates of drug development costs. Journal of Health Economics, 22, 151 185.
16. European Commission (2005) Key. Brussels : DG Research, Commission of the European Communities.
17. Forfás (2005) Business Expenditure on Research and Development (BERD), Ireland 2003/4. Dublin : Science and Technology Indicators Unit, Forfás.
18. Gassmann, O. Han, Z. (2004) Motivations and barriers of foreign R&D activities in China. R&D Management, 34, 349 365.
19. Gassmann, O. von Zedtwitz, M. (2003) Trends and determinants of managing virtual R&D teams. R&D Management, 33, 243 262.
20. Hagerdoorn, J. (2002) Inter-firm R&D partnerships: an overview of major trends and patterns since 1960. Research Policy, 31, 477 492.
21. Haour, G. (1992) Stretching the knowledge-base of the enterprise through contract research. R&D Management, 22, 177 182.
22. Howells, J. (1990a) The internationalisation of R&D and the development of global research networks. Regional Studies, 24, 495 512.
23. Howells, J. (1990b) The location and organisation of research and development: new horizons. Research Policy, 19, 133 146.
24. Howells, J. (1995) Going global: the use of ICT networks in research and development. Research Policy, 24, 169 184.
25. Howells, J. (1999) Research and technology outsourcing. Technology Analysis and Strategic Management, 11, 591 603.
26. Howells, J., Gagliardi, D. Malik, K. (2008) The growth and management of R&D outsourcing: the case of UK pharmaceuticals. R&D Management, 38, 205 219.
27. Howells, J., James, A. Malik, K. (2003) The sourcing of technological knowledge: distributed innovation processes and dynamic change. R&D Management, 33, 395 409.
28. Katz, R. Allen, T.J. (1985) Project performance and the locus of influence in the R&D matrix. Academy of Management Journal, 28, 67 87.
29. Jones, G.K. Teegan, H.J. (2003) Factors affecting foreign R&D location decisions: management and host policy implications. International Journal of Technology Management, 25, 791 813.
30. Jones, O. (2000) Innovation management as a post-modern phenomenon: the outsourcing of pharmaceutical R&D. British Journal of Management, 11, 341 356.
31. Lam, A. (2005) Work roles and careers of R&D scientists in network organizations. Industrial Relations, 44, 242 275.
32. Lane, P.J. Lubatkin, M. (1998) Relative absorptive capacity and interorganizational learning. Strategic Management Journal, 19, 461 477.
33. Le Bas, C. Sierra, C. (2002) 'Location versus home country advantages' in R&D activities: some further results on multinationals' locational strategies. Research Policy, 31, 589 609.
34. Liebenau, J. (1984) International R&D in pharmaceutical firms in the early twentieth century. Business History, 26, 329 346.
35. Madhavan, R., Koka, B.R. Prescott, J.E. (1998) Networks in transition: how industry events (re)shape interfirm relationships. Strategic Management Journal, 19, 439 459.
36. Mikkola, J.H. (2003) Modularity, component outsourcing, and inter-firm learning. R&D Management, 33, 439 454.
37. Miller, R. (1994) Global R&D networks and large-scale innovations: the case of the automobile industry. Research Policy, 23, 27 46.
38. National Science Foundation (2005) National Patterns of Research and Development Resources: 2003. Arlington, VA : Division of Science Resources Statistics, Directorate for Social, Behavioral, and Economic Sciences, National Science Foundation.
39. National Science Foundation (2006) Science and Engineering Indicators, 2006. Arlington, VA : National Science Foundation.
40. OECD (1963) The Measurement of Scientific and Technical Activities: Proposed Standard Practice for Surveys of Research and Experimental Development (Frascati Manual). Paris : OECD.
41. OECD (1981) The Measurement of Scientific and Technical Activities: Proposed Standard Practice for Surveys of Research and Experimental Development. Paris : OECD.
42. OECD (1989) The Measurement of Scientific and Technical Activities: Proposed Standard Practice for Surveys of Research and Experimental Development (Supplement to the Frascati Manual). Paris : OECD.
43. OECD (2002) Frascati Manual: Standard Method Proposed for Surveys of Experimental Research and Development. Paris : OECD.
44. OECD (2005) Internationalisation of R&D: Trends, Issues and Implications for S&T Policies. Background Report, Forum on the Internationalisation of R&D, 29-30 March, 2005, Brussels.
45. Orsenigo, L., Pammolli, F. Riccaboni, M. (2001) Technological change and network dynamics: lessons from the pharmaceutical industry. Research Policy, 30, 485 508.
46. Pisano, G.P. (1990) The R&D boundaries of the firm: an empirical analysis. Administrative Science Quarterly, 35, 153 176.
47. Powell, W.W. (1998) Learning from collaboration: knowledge and networks in the biotechnology and pharmaceutical industries. California Management Review, 40, 228 240.
48. Radjou, N. (2006) Does corporate R&D still matter? Research Technology Management, 49, 6 7.
49. Salomo, S., Steinhoff, F. Trommsdorff, V. (2003) Customer orientation in innovation projects and new product development success - the moderating effect of product innovativeness. International Journal of Technology Management, 26, 442 463.
50. Sanderson, M. (1972) Research and the firm in British industry, 1919-39. Science Studies, 2, 107 151.
51. Stalk, G. Hout, T.M. (1990) Competing Against Time: How Time-Based Competition is Reshaping Global Markets. New York : The Free Press.
52. Tapon, F. Thong, M. (1999) Research collaboration by multi-national research oriented pharmaceutical firms: 1988-1997. R&D Management, 29, 219 231.
53. UNCTAD (2005) Transnational Corporations and the Internationalization of R&D World Investment Report, United Nations, New York and Geneva.
54. von Hippel, E. (2005) Democratising Innovation. Cambridge, MA : The MIT Press, Massachusetts Institute of Technology.
55. Zedtwitz, M., von Gassmann, O. Boutelier, R. (2004) Organizing global R&D: challenges and dilemmas. Journal of Innovation Management, 10, 21 49.